Healthcare Sector Stocks 2026
Top healthcare stocks including pharmaceuticals, biotechnology, medical devices, and health insurance companies.
The healthcare sector includes pharmaceutical companies, biotechnology innovators, medical device manufacturers, health insurers, and healthcare services. This defensive sector benefits from aging demographics and continuous medical innovation.
Top 20 Healthcare Sector Stocks
LLY
Market Cap
—
P/E Ratio
—
UNH
Market Cap
—
P/E Ratio
—
JNJ
Market Cap
—
P/E Ratio
—
ABBV
Market Cap
—
P/E Ratio
—
MRK
Market Cap
—
P/E Ratio
—
TMO
Market Cap
—
P/E Ratio
—
ABT
Market Cap
—
P/E Ratio
—
DHR
Market Cap
—
P/E Ratio
—
PFE
Market Cap
—
P/E Ratio
—
AMGN
Market Cap
—
P/E Ratio
—
BMY
Market Cap
—
P/E Ratio
—
GILD
Market Cap
—
P/E Ratio
—
VRTX
Market Cap
—
P/E Ratio
—
CVS
Market Cap
—
P/E Ratio
—
CI
Market Cap
—
P/E Ratio
—
REGN
Market Cap
—
P/E Ratio
—
ISRG
Market Cap
—
P/E Ratio
—
ZTS
Market Cap
—
P/E Ratio
—
BSX
Market Cap
—
P/E Ratio
—
MDT
Market Cap
—
P/E Ratio
—
Stock Analysis Tools
Compare Top Stocks
Frequently Asked Questions
What are the best healthcare stocks?
Top healthcare stocks include UnitedHealth (UNH), Eli Lilly (LLY), Johnson & Johnson (JNJ), and innovative biotech companies like Vertex (VRTX) and Regeneron (REGN). The sector offers both growth and defensive characteristics.
What is the difference between pharma and biotech stocks?
Pharmaceutical companies typically have established drug portfolios and stable revenues (JNJ, MRK), while biotech companies (VRTX, REGN) focus on innovative therapies and may be pre-revenue or have concentrated product portfolios, making them higher risk but potentially higher reward.
Are healthcare stocks recession-proof?
Healthcare is considered defensive because demand for medical care remains relatively stable during economic downturns. However, specific segments like elective procedures and biotech can be more cyclical.
How do drug patents affect pharma stocks?
Patent expirations can significantly impact pharmaceutical stocks as generic competition reduces revenue. Investors should monitor pipeline drugs and patent cliffs when evaluating pharma companies.
Related Sectors
Get AI-Powered Stock Analysis
Access detailed DCF valuations, AI insights, and comprehensive analysis for any stock
Start Research